Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision Both sides next revision
covid:unpublished [2020/07/02 16:05]
biogridadmin
covid:unpublished [2020/07/02 16:14]
biogridadmin
Line 19: Line 19:
 |  **888800000012** ​ |  **[[https://​doi.org/​10.1101/​2020.03.31.019216|10.1101/​2020.03.31.019216]]** ​ |  Liang Q (2020) ​ | **[[https://​thebiogrid.org/​221199/​publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** ​ | |  **888800000012** ​ |  **[[https://​doi.org/​10.1101/​2020.03.31.019216|10.1101/​2020.03.31.019216]]** ​ |  Liang Q (2020) ​ | **[[https://​thebiogrid.org/​221199/​publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** ​ |
 |  **888800000013** ​ |  **[[https://​doi.org/​10.1101/​2020.04.15.042085|10.1101/​2020.04.15.042085]]** ​ |  Bestle D (2020) ​ | **[[https://​thebiogrid.org/​221402/​publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** ​ | |  **888800000013** ​ |  **[[https://​doi.org/​10.1101/​2020.04.15.042085|10.1101/​2020.04.15.042085]]** ​ |  Bestle D (2020) ​ | **[[https://​thebiogrid.org/​221402/​publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** ​ |
-|  **888800000014** ​ |  **[[https://​doi.org/​10.1101/​2020.04.09.033233|10.1101/​2020.04.09.033233]]** ​ |  Jin Z (2020) ​ | **[[https://​thebiogrid.org/​221403/​publication|Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug]]** ​ | 
-|  **888800000015** ​ |  **[[https://​doi.org/​10.1101/​2020.04.08.032763|10.1101/​2020.04.08.032763]]** ​ |  Yin W (2020) ​ | **[[https://​thebiogrid.org/​221404/​publication|Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir]]** ​ | 
 |  **888800000016** ​ |  **[[https://​doi.org/​10.1101/​2020.04.14.042010|10.1101/​2020.04.14.042010]]** ​ |  Chi X (2020) ​ | **[[https://​thebiogrid.org/​221405/​publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** ​ | |  **888800000016** ​ |  **[[https://​doi.org/​10.1101/​2020.04.14.042010|10.1101/​2020.04.14.042010]]** ​ |  Chi X (2020) ​ | **[[https://​thebiogrid.org/​221405/​publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** ​ |
 |  **888800000017** ​ |  **[[https://​doi.org/​10.1101/​2020.04.06.20055475|10.1101/​2020.04.06.20055475]]** ​ |  Ye L (2020) ​ | **[[https://​thebiogrid.org/​221565/​publication|Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor]]** ​ | |  **888800000017** ​ |  **[[https://​doi.org/​10.1101/​2020.04.06.20055475|10.1101/​2020.04.06.20055475]]** ​ |  Ye L (2020) ​ | **[[https://​thebiogrid.org/​221565/​publication|Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor]]** ​ |
 
covid/unpublished.txt · Last modified: 2021/04/24 15:17 by biogridadmin